FDA approves Eli Lilly's Alzheimer’s drug | Morning in America

NewsNation
NewsNation
1,244
0
Published 2024-07-03
The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. According to reports, this drug takes less time to slow the progression of the disease. It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients.

#FDA #Alzheimers #memoryloss

Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica

NewsNation is your source for fact-based, unbiased news for all America.

More from NewsNation: www.newsnationnow.com/
Get our app: trib.al/TBXgYpp
Find us on cable: trib.al/YDOpGyG
How to watch on TV or streaming: trib.al/Vu0Ikij
All Comments (10)
  • @KillaninjaFC
    Can we please not make this political and simply celebrate making a small step forward in a larger goal of treatment of a devastating disease? Thanks everyone!
  • @Ghostmanriding
    See the article from Stanford medicine, one step back,why Alzheimers plaque attack drugs don't work. It's always the same introduction with these expensive drugs.
  • @PeterCombs
    Get some to 1600 Penn Ave...RED ALERT...
  • @VagabondElixer
    And this is how the Apes evolved. I seen the movies! This will not end well. 😂
  • @chicagorandy
    News Update! Tanker truck containing the new chemical seen parked outside the White House.